Federal contract receipt
$51,049,267 from Department of Health and Human Services to MODEX THERAPEUTICS, INC
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
Signals
Full and openLarge awardMulti-year performance
Office of Federal Procurement Policy
Public Spend Intelligence - sledai.com
Award #CONT_AWD_75A50123C00056_7505_-NONE-_-NONE-
Signed2024-09-27
VendorMODEX THERAPEUTICS, INC
PlaceMA
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
Total obligated$51,049,267.00
PoP Start
2023-09-27
PoP End
2028-02-29
COMPETED
Awarded on 2024-09-27
Vendor
MODEX THERAPEUTICS, INC
Agency
Department of Health and Human Services
Category
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Place
MA
© 2025 Sled AI Inc. All rights reserved.